Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells

Planta Medica

Volumn 74, Issue 14, 2008, Pages 1693-1700

  Kim, Jong Bin ^a   Ko, Eunyoung ^b   Han, Wonshik ^b   Shin, Incheol ^c   Park, Seo Young ^b   Non, Dong Young ^a,b  

^a Cancer Research Institute   (Russian Federation)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

ABCG2; Berberine; Breast cancer; Cancer stem cells; Side population

Indexed keywords

BERBERINE; BREAST CANCER RESISTANCE PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BENZIMIDAZOLES; BERBERINE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORING AGENTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; STAINING AND LABELING;

EID: 57149096060     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1088313     Document Type: Article

References (30)

1. Phillips TM, McBride WH, Pajonk F. The response of CD24(-/low)/CD44+ breast cancer initiating cells to radiation. J Natl Cancer Inst 2006; 98: 1777-85
2. Burkert J, Otto W, Wright N. Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 2008; 214: 564-73
3. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827-33
4. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99: 507-12
5. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207-19
6. Lee S, Lim HJ, Park HV, Lee K S, Park J H, Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Artherosclerosis 2006; 186: 29-37
7. Jantova S, Cipak L, Cernakova M, Kost'alova D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 2003; 55: 1143-9
8. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004; 25: 496-502
9. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 2005; 25: 2170-6
10. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006; 27: 2018-27
11. Letasiova S, Jantova S, Miko M, Ovadekova R, Horvathova M. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol 2006; 58: 263-70
12. Orfila L, Rodriguez M, Colman T, Hasegawa M, Merentes E, Arvelo F. Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro. J Ethnopharmacol 2000; 71: 449-56
13. Kim JB, Lee KM, Ko E, Han W, Lee J E, Shin I et al. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 2008; 74: 39-42
14. Yin L, Castugnino P, Assoian RK. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition. Cancer Res 2008; 68: 800-7
15. Goodell MA. Multipotential stem cells and "side population" cells. Cytotherapy 2002; 4: 507-8
16. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu D M, Connolly D, Foster R et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci U S A 2006; 103: 11154-9
17. Wu C, Wei Q, Utomo V, Nadesan P, Whetstone H, Kandel R et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res 2007; 67: 8216-22
18. Zhou J, Wuljkuhle J, Zhang H, Gu P, Yang Y, Deng J et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007; 104: 16158-63
19. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A 2008: 105: 2445-50
20. Loontiens FG, Regenfuss P, Zechel A, Dumortier L, Clegg RM. Binding characteristics of Hoechst 33258 with calf thymus DNA. poly[d(A-T)]. and d(CCGGAATTCCCG): multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities. Biochemistry 1990; 29: 9029-39
21. Arndt-Jovin DJ, Jovin TM. Analysis and sorting of living cells according to deoxyribonucleic acid content. J Histochem Cytochem 1977; 25: 585-9
22. Gregoire M, Hernandez-Verdun D, Bouteille M. Visualization of chromatin distribution in living PTO cells by Hoechst 33342 fluorescent staining. Exp Cell Res 1984; 152: 38-46
23. Kang MR, Chung IK. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Mol Pharmacol 2002; 61: 879-84
24. Kim SA Kwon Y, Kim JH, Muller MT, Chung IK. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine. Biochemistry 1998; 37: 16316-24
25. 2+-ATPase. Biochim Biophys Acta 1984; 772: 29-36
26. Wu SN, Yu HS, Jan CR, Li HF, Yu CL. Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells. Life Sci 1998; 62: 2283-94
27. Shitan N, Tanaka M, Terai K, Ueda K, Yazaki K. Human MDR1 and MRP1 recognize berberine as their transport substrate. Biosci Biotechnol Biochem 2007; 71: 242-5
28. Kim M, Turnquist H, Jackson J, Sgagias M, Van Y, Gong M et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 2002; 8: 22-8
29. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-34
30. Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, Lehmann U. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 2007; 306: 201-12